Shan Gao, Ph.D.
Professor, Cell and Cancer Biology from Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences.
高山
中国科学院苏州生物医学工程技术研究所研究员,博士生导师,中科院百人计划获得者。英国牛津大学医学肿瘤学博士,江苏省“六大人才高峰”、苏州市“高校科研院所紧缺人才”计划获得者。中国生物工程学会理事(2015-2020),中国医院联盟学会分子诊断专业技术委员会委员(2017-2021)。科学通报编委和国家精准医学重点研发计划评审专家。主要方向有: 肿瘤分子基础和生物标志物; 药物机理等。
Shan Gao, DPhil-Oxon in Medical Oncology. Professor in Cell and Cancer Biology from Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences. My research focuses on the identification of driver mutation in cancer and the understanding of molecular mechanism of tumorgenesis; the identification of biomarker and the understanding of molecular mechanism for prediction to drug response. I have published more than 40 peer-reviewed papers including Science Advances, Cancer Research, Cell Reports etc. as a Corresponding Author. DNA methylation and lncRNAs have been shown to play the important roles in initiation, progression and metastasis of cancer, however, interaction between the DNA methylation and lncRNAs have not been extensively established. We mapped DNA methylation on promoter of lncRNAs and identified thousands of DNA-methylation regulated lncRNAs. I further investigated one lncRNA in role of renal carcinoma.
Sponsor/主办单位:
West China School of Medicine/
West China Hospital, Sichuan University
四川大学华西临床医学院/华西医院
Local Host/
承办单位:
Institutes for Systems Genetics, West China Hospital
华西医院系统遗传研究院
NeoTrident Technology Ltd (Suzhou)
苏州创腾数据科技有限公司